Pharmaceutical Information |
Drug Name |
Pentamidine isethionate |
Drug ID |
BADD_D01718 |
Description |
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. |
Indications and Usage |
For the treatment of pneumonia due to Pneumocystis carinii. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
P01CX01 |
DrugBank ID |
DB00738
|
KEGG ID |
D00834
|
MeSH ID |
D010419
|
PubChem ID |
8813
|
TTD Drug ID |
D05EAM
|
NDC Product Code |
23155-748; 39822-3050; 13925-515; 14593-930; 11712-790; 11712-788; 63323-113; 13925-522; 63323-877 |
Synonyms |
Pentamidine | Pentamidin | Lomidine | NebuPent | Pentamidine Isethionate | Pentam | Pentamidine Mesylate | Diamidine | Pentacarinat |
|
Chemical Information |
Molecular Formula |
C19H24N4O2.2C2H6O4S |
CAS Registry Number |
140-64-7 |
SMILES |
C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|